Eliem Therapeutics Pre-Tax Profit Margin 2021-2024 | CLYM
Eliem Therapeutics pre-tax profit margin from 2021 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Eliem Therapeutics Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.342B |
$0.000B |
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|